Sector Update: Healthcare

By
A A A

Healthcare shares are fairly flat in pre-market trade.

NPS Pharmaceuticals, Inc. ( NPSP ) announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.

NPSP is up 4% at $32.99, trading in a 52-week range of $7.35 to $35.72.

And, Biodel ( BIOD ) is up about 3% pre-market following a bullish SeekingAlpha article on Thursday.

Pointing to what he calls a "very promising pipeline in the works which already has big pharma taking notice and talking partnership", the writer said the stock is "extremely undervalued" and deserves a price per share 2 to 3 times the current valuation of $2.34.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: BIOD , NPSP

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

270,887,127
    $93.89 unch
225,243,115
  • $40.93 ▼ 2.74%
135,900,109
  • $47.52 ▲ 1.80%
89,467,924
  • $5.35 ▼ 1.11%
85,105,358
  • $16.95 ▼ 0.53%
80,748,539
  • $39.80 ▼ 4.21%
68,491,586
  • $3.57 ▼ 1.79%
62,097,356
  • $100.96 ▼ 0.82%
As of 9/19/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com